Tilaknagar Industries / Q3-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2026-02-10Back to TILAKNAGAR

Revenue

₹623 Cr

verified against source

Revenue YoY

90.5%

reported change

EBITDA

₹110 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q3 FY26: -105 · Positive source sentiment · 2026-02-10Q3 FY26-105-105
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Tilaknagar Industries reported a transformative Q3 FY26, with revenue surging 90.5% YoY to ₹664 crore, driven by the first month of Imperial Blue (IB) consolidation. EBITDA grew 82.3% YoY to ₹110 crore, with margins at 16.6%. IB contributed 1.8 million cases in December, helping TI achieve a 32% market share in southern India's prestige segment. Excluding IB, organic volumes grew 16.8% YoY. Management guided for 150-250 bps margin expansion for the combined business over 24-36 months and high single-digit to low double-digit volume growth in FY27. Key risks include integration disruptions, MML competition in Maharashtra, and elevated debt of ₹2,100 crore. The company expects net debt/EBITDA below 1x by FY29.

Colored figures show movement against the previous available record.

Guidance to track

  • Expect high single-digit to low double-digit volume growth for the combined business in FY27, followed by low double-digit growth in subsequent years.
  • Expect consolidated EBITDA margins to expand by 150 to 250 basis points over the next 24 to 36 months.
  • Expect Imperial Blue margins to expand by 250 to 350 basis points over the next 24 months from the steady-state margin of 11.7%.
  • Expect net debt to EBITDA ratio to go below 1 time by fiscal year 2029.

Risks flagged

  • Operational integration of Imperial Blue is complex; any disruption in bottling or distribution could impact volumes.
  • Introduction of MML in Maharashtra has caused the prestige segment to decline ~25%; IB maintained share but volumes are under pressure.
  • Debt of ₹2,100 crore with ballooning repayment structure; interest costs could pressure profitability.
  • Increased receivables from Telangana government are a concern; industry associations are engaging for clearance.

Key quotes

  • In the very first month of Imperial Blue under TI ownership, we achieved a combined secondary sale of 2.1 million cases in southern India in the month of December.
  • We are planning a phase-wise exit from TSMA with the aim of getting significant operations under TI belt by Q4 FI26.
  • During the integration phase, we are also undertaking cost-saving initiatives for the Imperial Blue business, which will result in margin expansion by 250 to 350 basis points on the acquired business over the next 24 months.

Research modules

Go one layer deeper.